Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 35Rectal Neoplasms 24Stomach Neoplasms 19Triple Negative Breast Neoplasms 16Colorectal Neoplasms 14Neoplasm Metastasis 12Adenocarcinoma 9Pancreatic Neoplasms 8Esophageal Neoplasms 8Parkinson Disease 4, Autosomal Dominant Lewy Body 7Nasopharyngeal Carcinoma 7Adenocarcinoma Of Esophagus 7Neoplasms 6Colonic Neoplasms 6Biliary Tract Neoplasms 5Carcinoma, Non-Small-Cell Lung 4Esophageal Squamous Cell Carcinoma 3Squamous Cell Carcinoma of Head and Neck 2Spinocerebellar Degenerations 2Pathologic Complete Response 2Ovarian Neoplasms 2Neoplasm, Residual 2Locally Advanced Rectal Cancer 2Carcinoma 2Anus Neoplasms 2Advanced Solid Tumour 2Somatostatinoma 1Solid Tumors 1Resectable Colon Cancer 1Rectal Cancer Patients 1

Interventions

paricalcitol 1mitazalimab 1Specimen Handling 1Positron Emission Tomography Computed Tomography 1Parturition 1Oxaliplatin 1Neoadjuvant Therapy 1Losartan 1Leucovorin 1Irinotecan 1Hydroxychloroquine 1Glucose 1Gemcitabine 1Fluorouracil 1Fecal Microbiota Transplantation 1Contrast Media 1Capecitabine 1Biopsy 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Ductal Adenocarcinoma × Capecitabine × 90 days × Clear all
NCT07024615 2026-05-28

A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer

Astellas Pharma Inc

Phase 1 Recruiting
25 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡